Recurrent Colon Cancer
75
0
0
55
Key Insights
Highlights
Success Rate
77% trial completion
Published Results
23 trials with published results (31%)
Research Maturity
55 completed trials (73% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 74/100
21.3%
16 terminated out of 75 trials
77.5%
-9.0% vs benchmark
7%
5 trials in Phase 3/4
42%
23 of 55 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 55 completed trials
Clinical Trials (75)
Sorafenib and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
Panitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With Bevacizumab
Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung Cancer
VEGF Trap in Treating Patients With Previously Treated Metastatic Colorectal Cancer
Ipilimumab and Local Radiation for Selected Solid Tumors
Isolated Hepatic Perfusion With Melphalan Followed By Chemotherapy in Treating Patients With Unresectable Colorectal Cancer That is Metastatic to the Liver
CPI-613 and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery
Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene
Chemoembolization Using Irinotecan in Treating Patients With Liver Metastases From Metastatic Colon or Rectal Cancer
Comprehensive Gene Sequencing in Guiding Treatment Recommendations Patients With Metastatic or Recurrent Solid Tumors
PET-MRI in Diagnosing Patients With Colon or Rectal Cancer
Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer
Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers
18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy
AZD0530 (NSC 735464) in Treating Patients With Previously Treated Metastatic Colon Cancer or Rectal Cancer
Hepatic Arterial Infusion of Floxuridine, Gemcitabine Hydrochloride, and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal Cancer Previously Treated With Surgery
Irinotecan and Alisertib in Treating Patients With Advanced Solid Tumors or Colorectal Cancer
Supportive Intervention Programs Study
Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
Irinotecan-Eluting Beads in Treating Patients With Refractory Metastatic Colon or Rectal Cancer That Has Spread to the Liver